MarketPeel
Insider Trading Intelligence
Pricing
…
Chair & CEO
Galbraith Kenneth
Thu, Jan 5, 2023
Jan 5
bought
$0.00
of
ZYME
215,000
shares @ $0.00
New position
23rd largest trade (out of 39)
Cluster Buy
Trade made by an officer
Part of a cluster of 9 transactions by 5 insiders
Unscheduled trade
Price 25% above 200-day moving average
ZYME
Zymeworks Inc.
Health Care
Pharmaceuticals
1D
0.00%
1W
+8.94%
1M
+4.82%
3M
—
6M
—
1Y
—
Recent insider activity at ZYME
Jan 12
Smith Jeffrey T L
Sold
$211.09k
Jan 12
Galbraith Kenneth
Sold
$689.82k
Jan 12
Moore Paul Andrew
Sold
$216.76k
Jan 12
Hollywood Mark
Sold
$138.76k
Jan 5
Moore Paul Andrew
Sold
$233.13k
Jan 5
Moore Paul Andrew
Sold
$271.57k
Jan 5
Galbraith Kenneth
Sold
$568.62k
Jan 5
Galbraith Kenneth
Sold
$795.22k
Full ZYME profile →
Galbraith Kenneth’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback